Clearline Capital LP Acquires 284,921 Shares of The Cooper Companies, Inc. $COO

Clearline Capital LP raised its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 299.4% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 380,090 shares of the medical device company’s stock after acquiring an additional 284,921 shares during the quarter. Cooper Companies accounts for approximately 1.2% of Clearline Capital LP’s investment portfolio, making the stock its 11th biggest position. Clearline Capital LP’s holdings in Cooper Companies were worth $26,059,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of COO. Buckhead Capital Management LLC raised its position in Cooper Companies by 14.3% in the 3rd quarter. Buckhead Capital Management LLC now owns 58,930 shares of the medical device company’s stock worth $4,040,000 after buying an additional 7,368 shares during the last quarter. First American Bank bought a new stake in shares of Cooper Companies in the third quarter worth approximately $1,646,000. Rakuten Investment Management Inc. bought a new stake in shares of Cooper Companies in the third quarter worth approximately $11,341,000. Amundi raised its holdings in shares of Cooper Companies by 35.5% during the second quarter. Amundi now owns 1,331,480 shares of the medical device company’s stock valued at $97,225,000 after purchasing an additional 348,652 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its position in Cooper Companies by 96.9% during the third quarter. Massachusetts Financial Services Co. MA now owns 3,099,750 shares of the medical device company’s stock valued at $212,519,000 after purchasing an additional 1,525,693 shares during the period. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analyst Ratings Changes

A number of research firms have commented on COO. Mizuho set a $100.00 target price on shares of Cooper Companies and gave the stock an “outperform” rating in a research report on Friday, December 5th. Needham & Company LLC raised their price target on Cooper Companies from $99.00 to $101.00 and gave the stock a “buy” rating in a research note on Friday, March 6th. Citigroup cut their price objective on Cooper Companies from $88.00 to $87.00 and set a “neutral” rating for the company in a report on Friday, March 6th. Rothschild & Co Redburn downgraded Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price on the stock. in a report on Wednesday, March 4th. Finally, William Blair raised Cooper Companies to a “strong-buy” rating in a research report on Friday, January 30th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $90.79.

Insiders Place Their Bets

In related news, Director Lawrence Erik Kurzius acquired 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, December 17th. The stock was bought at an average cost of $82.50 per share, for a total transaction of $165,000.00. Following the purchase, the director owned 7,777 shares in the company, valued at $641,602.50. The trade was a 34.62% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Maria Rivas bought 1,000 shares of Cooper Companies stock in a transaction that occurred on Thursday, December 18th. The stock was purchased at an average cost of $82.13 per share, with a total value of $82,130.00. Following the completion of the acquisition, the director directly owned 11,141 shares in the company, valued at $915,010.33. This represents a 9.86% increase in their position. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders have bought 16,014 shares of company stock valued at $1,304,416. 2.08% of the stock is currently owned by corporate insiders.

Cooper Companies Trading Down 2.2%

Shares of Cooper Companies stock opened at $69.92 on Friday. The Cooper Companies, Inc. has a 1-year low of $61.78 and a 1-year high of $89.83. The company’s fifty day simple moving average is $81.23 and its 200-day simple moving average is $75.96. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79. The stock has a market capitalization of $13.64 billion, a PE ratio of 34.61, a P/E/G ratio of 1.80 and a beta of 1.02.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.03 by $0.07. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The firm had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.02 billion. During the same period in the prior year, the business posted $0.92 EPS. Cooper Companies’s revenue was up 6.2% on a year-over-year basis. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.